课题基金 / 基金详情

蛋白激酶MST1/2活性切割片段负调控肾小管上皮细胞p65核转位抑制肾纤维化的分子机制研究

批准号:
82100706
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
徐春华
依托单位:
学科分类:
泌尿系统损伤与修复
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
徐春华

项目摘要

结项摘要

相似基金

相关文献

中文摘要
肾纤维化中受损肾小管上皮细胞炎症反应的分子机理尚未阐明。我们前期研究证实,肾小管特异性Mst1/2(哺乳动物Ste20样激酶1/2)敲除小鼠会自发肾纤维化,并以缺陷型肾小管上皮细胞来源的炎症因子分泌增多为诱因。预实验发现:正常小鼠肾脏中MST1/2以大约36 kD活性切割片段(C-MST1/2)为主;纤维化小鼠肾脏中C-MST1/2表达显著降低;进一步发现小鼠肾内髓集合管细胞过表达C-MST1/2能抑制TNF-α引起的p65入核。据此推测:C-MST1/2可能是肾纤维化的抑制分子,其通过负调控p65核转位来抑制肾小管上皮细胞炎症反应及肾间质纤维化。本课题拟采用水动力转染、定点突变、蛋白过表达等技术阐明C-MST1/2对肾纤维化的抑制作用,并以C-MST1/2表达失调介导p65核转位为新视点揭示肾小管上皮细胞炎症反应的分子机制,为肾纤维化的防治及早期炎症干预提供新思路。
英文摘要
The molecular mechanism underlying inflammatory response of injured tubular epithelial cells in renal fibrosis remains elusive. Our previous study has confirmed that tubule-specific Mst1/2 (mammalian Ste20-like kinase 1/2) knockout leads to spontaneous renal fibrosis in mice, and increased secretion of inflammatory factors that derived from defective tubular cells triggers the fibrotic progression. Preliminary data show that MST1/2 in normal mouse kidney exist mainly as truncated 36 kD active fragments (C-MST1/2); expression of C-MST1/2 is significantly reduced in fibrotic kidney; furthermore, overexpression of C-MST1/2 inhibits p65 nuclear translocation induced by TNF-α in mouse inner medullary collecting duct (mIMCD3) cells. On this basis, we speculate that C-MST1/2 may serve as inhibitory molecules to suppress inflammatory response of tubular cells and renal tubulointerstitial fibrosis through negative regulation of p65 nuclear translocation. This study aims to elucidate the inhibitory role of C-MST1/2 in renal fibrosis, and reveal the molecular mechanism of inflammatory response in tubular epithelial cells resulted from imbalanced C-MST1/2-mediated p65 nuclear translocation by hydrodynamic transfection, site-directed mutagenesis, protein overexpression, etc., which may provide new thoughts in prevention and intervention of early inflammation in renal fibrosis.
尽管急性肾损伤与慢性肾脏病在病因和症状上存在差异,但急性肾损伤和慢性肾脏病具有共同的机制,包括肾脏炎症和肾小管细胞死亡。肾脏炎症是肾脏损伤的初始反应,其目的是解决肾脏损伤。然而,未解决的持续性炎症会破坏肾脏结构并损害肾脏功能。我们前期研究发现,特异性敲除肾小管MST1/2后,在基础条件下,敲除小鼠早期即出现肾脏炎症反应,该炎症持续性进展并诱发肾小管损伤,形成恶性循环。然而,在病理条件下,蛋白激酶MST1/2的重要性仍有待确定。本项目发现在顺铂诱导的急性肾损伤和单侧输尿管结扎手术诱导的肾纤维化模型中,肾脏组织中MST1的表达均显著性上调,并与肾脏损伤的严重程度呈正相关;抑制MST1可明显减轻受损肾脏的炎症反应、肾小管损伤、纤维化及改善肾功能;在行单侧输尿管结扎术的小鼠肾脏中过表达MST1,会进一步加重受损肾脏的炎症反应和纤维化病变;体外实验结果提示,在既有损伤情况下,蛋白激酶MST1参与调控NF-κB信号通路,并通过增强NF-κB p65的磷酸化水平和核转位来发挥促炎、促纤维化作用。蛋白激酶MST1可能作为治疗肾脏炎症和纤维化的潜在靶点。
国内基金
海外基金